Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations.


Journal

PharmacoEconomics - open
ISSN: 2509-4254
Titre abrégé: Pharmacoecon Open
Pays: Switzerland
ID NLM: 101700780

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 28 6 2018
medline: 28 6 2018
entrez: 28 6 2018
Statut: ppublish

Résumé

Time trade-off (TTO) is an established method in health economics to elicit and value individuals' preferences for different health states. These preferences are expressed in the form of health-state utilities that are typically used to measure health-related quality of life and calculate quality-adjusted life-years in an economic evaluation. The TTO approach to directly elicit health-state utilities is particularly valuable when generic instruments (e.g. EQ-5D) may not fully capture changes in utility in a clinical trial. However, there is limited guidance on how a TTO study should be conducted alongside a clinical trial despite it being a valuable tool. We present an account of the design and development of a TTO study within a clinical trial as a case study. We describe the development of materials needed for the TTO interviews, the piloting of the TTO materials and interview process, and recommendations for future TTO studies. This paper provides a practical guide and reference for future applications of the TTO method alongside a clinical trial.

Identifiants

pubmed: 29949064
doi: 10.1007/s41669-018-0084-1
pii: 10.1007/s41669-018-0084-1
pmc: PMC6393276
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5-20

Subventions

Organisme : Department of Health
ID : 10/57/23
Pays : United Kingdom
Organisme : Health Technology Assessment Programme
ID : 10/57/23

Commentaires et corrections

Type : ErratumIn

Références

J Health Econ. 1996 Apr;15(2):209-31
pubmed: 10159110
J Health Econ. 1986 Mar;5(1):1-30
pubmed: 10311607
Med Decis Making. 1998 Oct-Dec;18(4):391-9
pubmed: 10372581
Med Decis Making. 2001 Jul-Aug;21(4):295-306
pubmed: 11475386
Med Decis Making. 2004 Nov-Dec;24(6):625-33
pubmed: 15534343
Eur J Health Econ. 2013 Jul;14 Suppl 1:S53-64
pubmed: 23900665
Value Health. 2014 Jun;17(4):445-53
pubmed: 24969006
Trials. 2015 Dec 30;16:600
pubmed: 26718754
Pharmacoeconomics. 2016 Oct;34(10):993-1004
pubmed: 27084198
Health Econ. 2018 Jan;27(1):7-22
pubmed: 28833869
Value Health. 2018 May;21(5):605-611
pubmed: 29753359
Health Econ. 1994 May-Jun;3(3):157-68
pubmed: 7921059
Health Econ. 1996 Mar-Apr;5(2):141-54
pubmed: 8733106
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889

Auteurs

Jing Shen (J)

Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle, UK. jing.shen@newcastle.ac.uk.

Sarah Hill (S)

Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle, UK.

David Mott (D)

Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle, UK.
Office of Health Economics, London, UK.

Matthew Breckons (M)

Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle, UK.

Luke Vale (L)

Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle, UK.

Rob Pickard (R)

Institute of Cellular Medicine, Newcastle University, Newcastle, UK.

Classifications MeSH